Search
for
Sort by
Research 661–690 of 1000+
- The PDGF/PDGFR pathway as a drug target
- Hair Growth Cycle Affects Hair Follicle Destruction by Ruby Laser Pulses
- Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review
- Alopecia areata: An update
- Acute diffuse and total alopecia: A new subtype of alopecia areata with a favorable prognosis
- Adverse Cutaneous Reactions to Mood Stabilizers
- Adverse Cutaneous Reactions to Antidepressants
- Tissue resident and follicular Treg cell differentiation is regulated by CRAC channels
- Side effects of common acne treatments
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Chaos and antichaos in pathology
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Topical absorption and systemic toxicity
- Anticonvulsant-Induced Cutaneous Reactions
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin
- Menopausal Acne – Challenges And Solutions
- Non-hemorrhage-related adverse effects of rivaroxaban
- Spectrum of mucocutaneous manifestations in human immunodeficiency virus-infected patients and its correlation with CD4 lymphocyte count
- Clinical Development of Topoisomerase-Interactive Drugs
- Hair loss
- Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
- Autoimmune gastritis and parietal cell reactivity in two children with abnormal intestinal permeability
- Fixed-Drug Eruption due to Dextromethorphan
- Adverse cutaneous effects of psychotropic medications
- Acne
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review